YU57701A - Veštački peptidi koji imaju površinsku aktivnost i njihova upotreba u pripremi veštačkog surfaktanta - Google Patents

Veštački peptidi koji imaju površinsku aktivnost i njihova upotreba u pripremi veštačkog surfaktanta

Info

Publication number
YU57701A
YU57701A YU57701A YUP57701A YU57701A YU 57701 A YU57701 A YU 57701A YU 57701 A YU57701 A YU 57701A YU P57701 A YUP57701 A YU P57701A YU 57701 A YU57701 A YU 57701A
Authority
YU
Yugoslavia
Prior art keywords
artificial
surface activity
preparation
peptides
surfactant
Prior art date
Application number
YU57701A
Other languages
English (en)
Inventor
Tore Curstedt
Jan Johansson
Hans Jornvall
Bengt Robertson
Paolo Ventura
Original Assignee
Chiesi Farmaceutici S.P.A.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chiesi Farmaceutici S.P.A. filed Critical Chiesi Farmaceutici S.P.A.
Publication of YU57701A publication Critical patent/YU57701A/sh

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/785—Alveolar surfactant peptides; Pulmonary surfactant peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/16—Otologicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pulmonology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Opisani su SP-C analogni veštački peptidi koji imaju površinsku aktivnost i njihova upotreba za pripremanje veštačkih surfaktanata korisnih za tretman sindroma respiratornog distresa (RDS) i drugih oboljenja povezanih sa nedostatkom ili disfunkcijom surfaktanta.[SP-C analogue artificial peptides having surface activity are disclosed and their use for preparing artificial surfactants useful in the treatment of respiratory distress syndrome (RDS) and other diseases related to surfactant deficiency or dysfunction.
YU57701A 1999-02-12 2000-02-09 Veštački peptidi koji imaju površinsku aktivnost i njihova upotreba u pripremi veštačkog surfaktanta YU57701A (sh)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT1999MI000275A IT1308180B1 (it) 1999-02-12 1999-02-12 Peptidi sintetici aventi la capacita' di diminuire la tensionesuperficiale e loro impiego nella preparazione di un surfattante

Publications (1)

Publication Number Publication Date
YU57701A true YU57701A (sh) 2003-07-07

Family

ID=11381859

Family Applications (1)

Application Number Title Priority Date Filing Date
YU57701A YU57701A (sh) 1999-02-12 2000-02-09 Veštački peptidi koji imaju površinsku aktivnost i njihova upotreba u pripremi veštačkog surfaktanta

Country Status (33)

Country Link
US (1) US7053044B1 (sh)
EP (1) EP1151008B1 (sh)
JP (1) JP4754073B2 (sh)
KR (1) KR100645145B1 (sh)
CN (1) CN1221570C (sh)
AR (1) AR022578A1 (sh)
AT (1) ATE280181T1 (sh)
AU (1) AU758735B2 (sh)
BG (1) BG65196B1 (sh)
BR (1) BR0009964A (sh)
CA (1) CA2362507C (sh)
CO (1) CO5241361A1 (sh)
CZ (1) CZ301108B6 (sh)
DE (1) DE60015082T2 (sh)
EA (1) EA004058B1 (sh)
EE (1) EE04879B1 (sh)
ES (1) ES2228473T3 (sh)
GE (1) GEP20032976B (sh)
HK (1) HK1042500A1 (sh)
HU (1) HU228997B1 (sh)
IL (1) IL144842A0 (sh)
IT (1) IT1308180B1 (sh)
MA (1) MA25381A1 (sh)
NO (1) NO20013888D0 (sh)
NZ (1) NZ513451A (sh)
PL (1) PL201084B1 (sh)
PT (1) PT1151008E (sh)
SK (1) SK286428B6 (sh)
TR (1) TR200102308T2 (sh)
UA (1) UA72751C2 (sh)
WO (1) WO2000047623A1 (sh)
YU (1) YU57701A (sh)
ZA (1) ZA200106530B (sh)

Families Citing this family (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1308180B1 (it) * 1999-02-12 2001-12-07 Chiesi Farma Spa Peptidi sintetici aventi la capacita' di diminuire la tensionesuperficiale e loro impiego nella preparazione di un surfattante
CA2399944A1 (en) * 2000-02-11 2001-08-16 Altana Pharma Ag Novel use of pulmonary surfactant for the prophylaxis and treatment of chronic pulmonary diseases
SI1340506T1 (sl) * 2002-03-01 2007-04-30 Chiesi Farma Spa Sestavki, ki vsebujejo pljucne surfaktante in polimiksin z izboljsanimi povrsinskimi lastnostmi
ITMI20021058A1 (it) 2002-05-17 2003-11-17 Chiesi Farma Spa Miscele di lipidi sintetici ottimizzate per la preparazione di un surfattante ricostituito
CN100401896C (zh) * 2002-12-09 2008-07-16 儿童医院医疗中心 诊断和治疗间质性肺病的方法
EP1481665A1 (en) * 2003-05-30 2004-12-01 CHIESI FARMACEUTICI S.p.A. Novel lipid mixtures for synthetic surfactants
CA2536453A1 (en) * 2003-08-28 2005-03-10 Altana Pharma Ag Use of surfactant preparations for the treatment of surgical adhesions
US20060004185A1 (en) * 2004-07-01 2006-01-05 Leese Richard A Peptide antibiotics and peptide intermediates for their prepartion
US8337815B2 (en) * 2004-12-23 2012-12-25 Discovery Laboratories, Inc. Pulmonary surfactant formulations
CA2658478C (en) 2006-07-20 2018-02-13 University Of Rochester Synthetic lung surfactant and use thereof
DK2078038T3 (da) * 2006-10-13 2013-12-02 Chiesi Farma Spa Rekonstituerede surfaktanter med forbedrede egenskaber
EP1997502A1 (en) 2007-06-01 2008-12-03 CHIESI FARMACEUTICI S.p.A. Reconstituted surfactants having improved properties
US8048043B2 (en) 2007-06-08 2011-11-01 Chiesi Farmaceutici S. P. A. Method of administration of a pulmonary surfactant
EP2022798A1 (en) * 2007-08-09 2009-02-11 CHIESI FARMACEUTICI S.p.A. Synthetic pulmonary surfactant peptides
AR074874A1 (es) 2008-12-23 2011-02-16 Biosource Pharm Inc Composiciones antibioticas para el tratamiento de infecciones gram negativas. metodo. uso. compuesto.
CN102470150B (zh) 2009-09-08 2013-12-11 奇斯药制品公司 包含肺表面活性物质和抗氧化酶的治疗组合物
US8415307B1 (en) 2010-06-23 2013-04-09 Biosource Pharm, Inc. Antibiotic compositions for the treatment of gram negative infections
MA37431B1 (fr) * 2012-04-23 2016-06-30 Chiesi Farma Spa Procédé et système pour l'administration d'un surfactant pulmonaire par atomisation
AR093569A1 (es) 2012-11-21 2015-06-10 Chiesi Farm Spa Tensioactivos pulmonares reconstituidos
CN107666933A (zh) 2015-04-22 2018-02-06 奇斯药制品公司 用于药物有效地呼吸同步递送到肺部的方法和系统
EP3106090A1 (en) 2015-06-15 2016-12-21 CHIESI FARMACEUTICI S.p.A. System for effective breath-synchronized delivery of medicament to the lungs
US11311691B2 (en) 2015-04-28 2022-04-26 Chiesi Farmaceutici S.P.A Device for facilitating the administration of a medicament to the lung by a catheter
EP3288579A1 (en) 2015-04-30 2018-03-07 University of Bremen A novel skin medical and cosmetic care product
EP3490649A1 (en) 2016-07-28 2019-06-05 Chiesi Farmaceutici S.p.A. Method and system for delivery of an aerosolized medicament
CN109890446B (zh) 2016-10-26 2022-03-22 奇斯药制品公司 用于帮助通过导管向肺给送药剂的装置
RU2757902C2 (ru) 2016-12-22 2021-10-22 КЬЕЗИ ФАРМАЧЕУТИЧИ С.п.А. Терапевтическая комбинация для лечения развивающейся bpd, содержащая легочный сурфактант и стероид
WO2019115771A1 (en) 2017-12-15 2019-06-20 Pari Pharma Gmbh Nebuliser system, holding system, combination comprising nebuliser system and holding system, and aerosol administration method
TW201927286A (zh) 2017-12-15 2019-07-16 義大利商凱西製藥公司 用於噴霧投藥之包含肺表面張力素的藥學調配物
WO2019206731A1 (en) 2018-04-23 2019-10-31 Chiesi Farmaceutici S.P.A. A therapeutic combination comprising a pulmonary surfactant and a steroid for the prophylaxis of bpd
EP3666315A1 (en) 2018-12-14 2020-06-17 PARI Pharma GmbH Aerosol delivery device and method of operating the aerosol delivery device
EP3666316A1 (en) 2018-12-14 2020-06-17 PARI Pharma GmbH Aerosol delivery device and method of operating the aerosol delivery device
EP3843105A1 (en) 2019-12-23 2021-06-30 PARI Pharma GmbH Control device for aerosol nebulizer system
WO2021151853A1 (en) 2020-01-28 2021-08-05 Chiesi Farmaceutici S.P.A. Polypeptides having improved properties
CN114159546B (zh) * 2021-12-20 2024-06-04 北京双鹤润创科技有限公司 新一代合成肺表面活性物质制剂及其临床应用
EP4411745A1 (en) 2023-02-01 2024-08-07 Pari Medical Holding GmbH Medical evaluation method, aerosol nebulizer and medical evaluation system

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5104853A (en) 1984-12-11 1992-04-14 California Biotechnology Inc. Alveolar surfactant proteins having cys to ser mutations
SE8803713D0 (sv) * 1988-10-18 1988-10-18 Kabigen Ab Biologically active lipoprotein and its use
ES2189825T3 (es) * 1993-12-08 2003-07-16 Mitsubishi Pharma Corp Nuevo peptido sintetico, tensioactivo pulmonar que lo contiene y remedio para el sindrome de malestar respiratorio.
DE4418936A1 (de) * 1994-05-31 1996-02-08 Byk Gulden Lomberg Chem Fab Polypeptid
IT1308180B1 (it) * 1999-02-12 2001-12-07 Chiesi Farma Spa Peptidi sintetici aventi la capacita' di diminuire la tensionesuperficiale e loro impiego nella preparazione di un surfattante

Also Published As

Publication number Publication date
EA200100749A1 (ru) 2002-02-28
KR20010101904A (ko) 2001-11-15
MA25381A1 (fr) 2002-04-01
HK1042500A1 (en) 2002-08-16
EE04879B1 (et) 2007-08-15
SK11442001A3 (sk) 2001-12-03
HUP0200141A3 (en) 2002-09-30
CA2362507A1 (en) 2000-08-17
ZA200106530B (en) 2002-10-14
HU228997B1 (en) 2013-07-29
PL201084B1 (pl) 2009-03-31
CZ301108B6 (cs) 2009-11-11
BG65196B1 (bg) 2007-06-29
ES2228473T3 (es) 2005-04-16
BG105764A (en) 2002-03-29
CN1340060A (zh) 2002-03-13
DE60015082T2 (de) 2006-02-09
NO20013888L (no) 2001-08-09
CN1221570C (zh) 2005-10-05
BR0009964A (pt) 2002-04-09
CZ20012876A3 (cs) 2002-06-12
ITMI990275A1 (it) 2000-08-12
NO20013888D0 (no) 2001-08-09
PL349785A1 (en) 2002-09-09
US7053044B1 (en) 2006-05-30
IT1308180B1 (it) 2001-12-07
CA2362507C (en) 2012-01-03
HUP0200141A2 (en) 2002-06-29
GEP20032976B (en) 2003-05-27
IL144842A0 (en) 2002-06-30
EA004058B1 (ru) 2003-12-25
KR100645145B1 (ko) 2006-11-10
SK286428B6 (sk) 2008-09-05
EP1151008B1 (en) 2004-10-20
NZ513451A (en) 2003-05-30
TR200102308T2 (tr) 2002-04-22
JP4754073B2 (ja) 2011-08-24
WO2000047623A1 (en) 2000-08-17
PT1151008E (pt) 2005-01-31
JP2002541062A (ja) 2002-12-03
EE200100413A (et) 2002-12-16
DE60015082D1 (de) 2004-11-25
AU758735B2 (en) 2003-03-27
CO5241361A1 (es) 2003-01-31
AU3279300A (en) 2000-08-29
AR022578A1 (es) 2002-09-04
ATE280181T1 (de) 2004-11-15
EP1151008A1 (en) 2001-11-07
UA72751C2 (en) 2005-04-15

Similar Documents

Publication Publication Date Title
YU57701A (sh) Veštački peptidi koji imaju površinsku aktivnost i njihova upotreba u pripremi veštačkog surfaktanta
BG101028A (en) Synthetic peptide analogs of lung surfactant protein sp-c
GR3019901T3 (en) Osteoinductive pharmaceutical formulations
DE60043229D1 (de) Zusammensetzung zur gefässbeschichtung
NZ224992A (en) Factor viii analogues and their preparation
NZ227788A (en) Peptide having growth hormone regulatory effects, and compositions
PL347590A1 (en) Oxazolo, thiazolo and selenazolo [4,5-c]-quinolin-4-amines and analogs thereof
WO1998033509A3 (en) Useful properties of human lactoferrin and variants thereof
IL138665A0 (en) Peptide factor
SG160205A1 (en) Modified polypeptide
TW240170B (sh)
ATE374618T1 (de) Verwendung von rekombinanten menschlichen uteroglobin zur behandlung von fibrotischen krankheitszuständen
WO2000037487A8 (de) INHIBITOREN DES INTEGRINS αvβ¿6?
NO983177L (no) Anvendelse av 1-enantiomeren av centkroman til fremstilling av et farmasaytisk preparat for behandling eller profylakse av brystkreft
IL165239A (en) Reconstituted surfactant comprising an artificial sp-c peptide analog and a phospholipid mixture, a process for its production and use thereof in the manufacture of medicaments for treating pulmonary dysfunction
KR100488038B1 (ko) 기관 보호 활성을 지닌 신규한 신체 보호 화합물 펩티드염, 이의 제조 방법 및 치료에서의 이의 용도
HK1092162A1 (en) Biologically active peptides comprising isoleucyl-valyl-threonyl- asparaginyl-threonyl-threonine (ivtntt)
WO2002012336A3 (en) TGF-β THERAPEUTICS, COMPOSITIONS AND METHODS OF USE
IL154775A0 (en) 21-hydroxy-6, 19-oxidoprogesterone (21oh-6, 19op) analogues, their preparation and use
GB9723824D0 (en) Cytostatic agents
WO2001080811A3 (en) Mmp-2 propeptide for use as antiangiogenic or antitumor agent
WO2000022097A3 (en) Periferal blood mensenchymal precursor cells
SI1192184T1 (sl) Estri surfakantnega proteina C
NZ509773A (en) Casein formulations for the delivery of bioactive constituents
AU2717295A (en) Use of trinitrobenzenes or carminic acid in the treatment of cancer or viral diseases